Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRR | Q9GZT4 | 3/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 11/20 | 0.41 |
| ▸ | PPARA | Q07869 | 10/20 | 0.41 |
| ▸ | PSAT1 | Q9Y617 | 1/20 | 0.40 |
| ▸ | ALPI | P09923 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | XIAP | P98170 | 1/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8823359 | 0.88 | SRR (0.54) | SRRPPARGPPARA | |
| SCHEMBL1595266 | 0.88 | SRR (0.54) | SRRPPARGPPARA | |
| SCHEMBL27786693 | 0.87 | SRR (0.45) | SRRPPARGPPARAALPIPKM | |
| SCHEMBL8823316 | 0.85 | SRR (0.44) | SRRPPARGPPARA | |
| SCHEMBL4406213 | 0.85 | LDHA (0.48) | EPHX1PPARGPPARA | |
| SCHEMBL12755046 | 0.84 | ATM (0.44) | SRRPPARGPPARA | |
| SCHEMBL11202582 | 0.84 | SRR (0.43) | SRRPPARGPPARA | |
| SCHEMBL1667087 | 0.82 | FAAH (0.44) | PPARGPPARA | |
| SCHEMBL2163274 | 0.81 | FAAH (0.46) | — | |
| SCHEMBL6740375 | 0.78 | PPARG (0.63) | PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11673869-B2 | 4-oxazolidinone antimicrobial agents | NORTH CAROLINA STATE UNIVERSITY (US) | 2023-06-13 | — | — | US | disclosed |
| US-11673869-B2 | 4-oxazolidinone antimicrobial agents | NORTH CAROLINA STATE UNIVERSITY (US) | 2023-06-13 | — | — | US | disclosed |
| US-20210323934-A1 | 4-OXAZOLIDINONE ANTIMICROBIAL AGENTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-10-21 | — | — | US | disclosed |
| US-10844025-B2 | 4-oxazolidinone antimicrobial agents | NORTH CAROLINA STATE UNIVERSITY (US) | 2020-11-24 | — | — | US | disclosed |
| US-20190177285-A1 | 4-OXAZOLIDINONE ANTIMICROBIAL AGENTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190177285-A1 | 4-OXAZOLIDINONE ANTIMICROBIAL AGENTS | OXA1L, MMP17, MMP2 | SRR 3871/4885EPHX1 4072/4885PPARG 1907/4885 |
| US-10844025-B2 | 4-oxazolidinone antimicrobial agents | OXA1L, MMP17, MMP2 | SRR 3871/4885EPHX1 4072/4885PPARG 1907/4885 |
| US-11673869-B2 | 4-oxazolidinone antimicrobial agents | OXA1L, MMP17, MMP2 | SRR 3871/4885EPHX1 4072/4885PPARG 1907/4885 |
| US-20210323934-A1 | 4-OXAZOLIDINONE ANTIMICROBIAL AGENTS | OXA1L, MMP17, MMP2 | SRR 3871/4885EPHX1 4072/4885PPARG 1907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.